INS and diabetes mellitus: Similarly, a longitudinal cross-sectional study on patients recruited from the diabetes prevention trial (PRELLIM) comparing metformin alone to metformin and linagliptin showed favorable outcomes of the combination on insulin sensitivity and pancreatic function [52].